Achilles Therapeutics plc (NASDAQ:ACHL – Get Rating) was the recipient of a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 14,800 shares, a growth of 114.5% from the April 30th total of 6,900 shares. Approximately 0.0% of the company’s shares are sold short. Based […]
Syncona Ltd on Wednesday said that its portfolio company Achilles Therapeutics PLC has made losses in the first quarter of 2023, with cash equivalents falling and expenses increasing.
Syncona is a. | May 10, 2023
Senior editor Fay Lin interviews Geulah Livshits,senior research analyst at Chardan,. She asks him to assess the advances and challenges facing the cell therapy field.
Achilles Therapeutics (ACHL) Granted US Patent Covering the Treatment of Patients with an Immunotherapy Targeting Neoantigens Based on Tumor HLA Status streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.